JP6222629B2 - 排尿障害のバイオマーカー - Google Patents

排尿障害のバイオマーカー Download PDF

Info

Publication number
JP6222629B2
JP6222629B2 JP2013178620A JP2013178620A JP6222629B2 JP 6222629 B2 JP6222629 B2 JP 6222629B2 JP 2013178620 A JP2013178620 A JP 2013178620A JP 2013178620 A JP2013178620 A JP 2013178620A JP 6222629 B2 JP6222629 B2 JP 6222629B2
Authority
JP
Japan
Prior art keywords
urine
amount
compounds represented
overactive bladder
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013178620A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015049050A (ja
JP2015049050A5 (enExample
Inventor
尚也 北村
尚也 北村
映里 清水
映里 清水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2013178620A priority Critical patent/JP6222629B2/ja
Publication of JP2015049050A publication Critical patent/JP2015049050A/ja
Publication of JP2015049050A5 publication Critical patent/JP2015049050A5/ja
Application granted granted Critical
Publication of JP6222629B2 publication Critical patent/JP6222629B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013178620A 2013-08-29 2013-08-29 排尿障害のバイオマーカー Active JP6222629B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013178620A JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013178620A JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Publications (3)

Publication Number Publication Date
JP2015049050A JP2015049050A (ja) 2015-03-16
JP2015049050A5 JP2015049050A5 (enExample) 2016-07-28
JP6222629B2 true JP6222629B2 (ja) 2017-11-01

Family

ID=52699210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013178620A Active JP6222629B2 (ja) 2013-08-29 2013-08-29 排尿障害のバイオマーカー

Country Status (1)

Country Link
JP (1) JP6222629B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7031104B2 (ja) * 2017-09-29 2022-03-08 国立大学法人山梨大学 難治性夜間頻尿・夜間多尿症バイオマーカー、これを用いた検査方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法
JP7294709B2 (ja) * 2017-09-29 2023-06-20 国立大学法人山梨大学 難治性夜間頻尿・夜間多尿症バイオマーカーの測定方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162899A (ja) * 1983-03-08 1984-09-13 Kyoto Daiichi Kagaku:Kk β‐ヒドロキシ酪酸の定量用組成物
US7700792B2 (en) * 2003-12-26 2010-04-20 Ono Pharmaceutical Co., Ltd. Highly active lysophosphatidic acid and method of screening therewith
EP2179292B1 (en) * 2007-08-16 2012-11-28 The Regents of the University of Michigan Metabolomic profiling of prostate cancer
DE112010002253T5 (de) * 2009-06-04 2013-01-03 Charité - Universitätsmedizin Berlin Mittel und Verfahren zur Diagnostizierung von Prostatakarzinomen
JP2013515270A (ja) * 2009-12-22 2013-05-02 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌の代謝学的プロファイリング
US20150065366A1 (en) * 2011-11-11 2015-03-05 Metabolon, Inc. Biomarkers for Bladder Cancer and Methods Using the Same

Also Published As

Publication number Publication date
JP2015049050A (ja) 2015-03-16

Similar Documents

Publication Publication Date Title
Meyer et al. Targeted quantification of C-reactive protein and cystatin c and its variants by immuno-MALDI-MS
US8951739B2 (en) Biomarker for depression, method for measuring a biomarker for depression, computer program, and recording medium
CN102105794B (zh) 移植物衰竭和死亡的标志物
JP6927212B2 (ja) 軽度認知障害又はアルツハイマー型認知症の評価方法
US20120196300A1 (en) Neurodegenerative Markers for Psychiatric Conditions
JP2020521114A (ja) 対象の喫煙ステータスを区別するための診断テスト
Alajbeg et al. Within‐subject reliability and between‐subject variability of oxidative stress markers in saliva of healthy subjects: A longitudinal pilot study
JP2013512444A (ja) 多発性硬化症を診断するための手段及び方法
JP2014501926A (ja) 糖尿病を予測する手段及び方法
Xu et al. An impedimetric assay of α-synuclein autoantibodies in early stage Parkinson's disease
WO2015060317A1 (ja) 神経変性疾患の検査方法
TW202016547A (zh) 腎病變蛋白生物標記及其應用
Falkowski et al. Insulin resistance is associated with impaired olfactory function in adult patients with type 1 diabetes: a cross‐sectional study
JP6222629B2 (ja) 排尿障害のバイオマーカー
WO2022181333A1 (ja) 軽度認知障害検査
JP6389184B2 (ja) サンプルにおいて代謝産物疾患バイオマーカーのクリアランス正規化量を決定するための手段及び方法
TWI735470B (zh) 糖尿病性腎病之判定方法、及於此種判定方法中生物標記之用途
WO2013080917A1 (ja) 統合失調症の客観的評価法
WO2015023626A1 (en) Sensitive diagnostic assay for inclusion body myositis
US9541543B2 (en) Method for diagnosing acute alcoholic hepatitis
Umakanthan et al. Prevalence and Factors Associated with Sarcopenia in Patients on Maintenance Dialysis in Australia—A Single Centre, Cross-Sectional Study. Nutrients 2021, 13, 3284
US20250130240A1 (en) Marker and device for diagnosing overall health status of individual
EP4286848A1 (en) Biomarker for diagnosis of dementia
JP2013253781A (ja) 神経変性疾患の検査方法及び神経変性疾患判定キット
JP7461037B2 (ja) 睡眠障害を判定するためのバイオマーカー

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160610

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160610

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160610

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170419

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170419

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170925

R150 Certificate of patent or registration of utility model

Ref document number: 6222629

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250